Concepedia

Yong Ren

YR

Statistics

Publications

15

Citations

815

H-Index

14

Active since

2004

Affiliations

The University of Texas Medical Branch at Galveston(Current)

Rockefeller University

DecImmune Therapeutics (United States)

Pfizer (United States)

Institute for Research in Immunology and Cancer

Yong Ren is an author at The University of Texas Medical Branch at Galveston specializing in pharmacology, life sciences, and medicine.

Publications per year

2004–2024

15

Publications

15

Pepducin targeting the C-X-C chemokine receptor type 4 acts as a biased agonist favoring activation of the inhibitory G protein

Julie Quoyer, Jay M. Janz, Jiansong Luo et al. · Proceedings of the National Academy of Sciences · 2013 · 181 citations · Full text

, , +17

Discovery of a CXCR4 agonist pepducin that mobilizes bone marrow hematopoietic cells

Boris Tchernychev, Yong Ren, Jay M. Janz et al. · Proceedings of the National Academy of Sciences · 2010 · 115 citations · Full text

, , +17

Sensitization of Primary Afferent Nociceptors Induced by Intradermal Capsaicin Involves the Peripheral Release of Calcitonin Gene-Related Peptide Driven by Dorsal Root Reflexes

Dingge Li, Yong Ren, Xijin Xu et al. · Journal of Pain · 2008 · 78 citations · Full text

, , +17

Direct Interaction between an Allosteric Agonist Pepducin and the Chemokine Receptor CXCR4

Jay M. Janz, Yong Ren, Richard Looby et al. · Journal of the American Chemical Society · 2011 · 73 citations · Full text

, , +15

Sulfatinib, a novel kinase inhibitor, in patients with advanced solid tumors: results from a phase I study

Jianming Xu, Yan Wang, Yu Ling Chen et al. · Oncotarget · 2017 · 57 citations · Full text

, , +14

1–5 of 15